Equity · Healthcare
KIDS
NASDAQOrthoPediatrics (KIDS)
This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers.
- Market cap
- 501.3M USD
- Revenue, year to Dec 2025
- 236.3M USD
- EPS, diluted, year to Dec 2025
- −1.69 USD
- 52-week range
- 14.65 USD – 23.64 USD
- Avg volume
- 25.1K
as of Jul 17, 2026
Have OrthoPediatrics (KIDS) insiders bought or sold shares recently?
In the 90 days to 10 Nov 2026, OrthoPediatrics insiders reported 21 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 10 Nov 2025, show no open-market purchase.
Form 4, 90 days to 10 Nov 2026, newest reported trade 10 Sep 2026
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 10 Sep 2026 | Pelizzon David RDirector | Sell | 302,369 | 6.4M USD |
| 10 Sep 2026 | Squadron Capital LLC10% Owner | Sell | 302,369 | 6.4M USD |
| 10 Sep 2026 | Pritzker Jennifer N.10% Owner | Sell | 302,369 | 6.4M USD |
| 02 Sep 2026 | Pelizzon David RDirector | Sell | 22,500 | 525K USD |
| 02 Sep 2026 | Squadron Capital LLC10% Owner | Sell | 22,500 | 525K USD |
| 02 Sep 2026 | Pritzker Jennifer N.10% Owner | Sell | 22,500 | 525K USD |
| 01 Sep 2026 | Pelizzon David RDirector | Sell | 10,131 | 234K USD |
| 01 Sep 2026 | Squadron Capital LLC10% Owner | Sell | 10,131 | 234K USD |
| 01 Sep 2026 | Pritzker Jennifer N.10% Owner | Sell | 10,131 | 234K USD |
| 28 Aug 2026 | Pelizzon David RDirector | Sell | 326,700 | 7.5M USD |
| 28 Aug 2026 | Squadron Capital LLC10% Owner | Sell | 326,700 | 7.5M USD |
| 28 Aug 2026 | Pritzker Jennifer N.10% Owner | Sell | 326,700 | 7.5M USD |
| Sold | 21 open-market sales | 2,100,000 | $46.75M |
Showing the 12 most recent of 21 open-market trades in this window. The figures above count all of them.
Which funds hold OrthoPediatrics (KIDS)?
7 of the 45 institutional funds we track reported a OrthoPediatrics position for the quarter ended 30 Jun 2026 — a combined 29.2M USD; the latest of those filings landed 02 Sep 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Millennium Management | Trimmed | 816,830 | 15.6M USD | −34.0% |
| Citadel Advisors | Added | 334,651 | 6.4M USD | +80.5% |
| Tudor Investment Corp | Held (±25%) | 170,022 | 3.3M USD | +0.6% |
| D. E. Shaw & Co. | Added | 91,415 | 1.7M USD | +25.1% |
| AQR Capital Management | New position | 78,291 | 1.5M USD | |
| Point72 Asset Management | Trimmed | 23,126 | 442K USD | −35.6% |
| Two Sigma Investments | New position | 10,598 | 203K USD | |
| Balyasny Asset Management | Exited |
What has been filed or recorded for OrthoPediatrics (KIDS)?
The filings we hold for OrthoPediatrics, newest first: 1 fails-to-deliver day, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 05 Oct 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 05 Oct 2026 | Fails to deliver | Shares failed to deliver | 7,138 shares | 158K USD notional · 0.027% of shares out |
| 30 Sep 2026 | Quarterly earnings | Q3 2026 reported | EPS −0.25 USD | |
| 30 Sep 2026 | Financials | Total assets | 509.1M USD | at period end |
| 30 Sep 2026 | Financials | Total equity | 339.4M USD | at period end |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS −0.30 USD | |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS −0.45 USD | |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS −1.69 USD | |
| 31 Dec 2025 | Financials | Revenue | 236.3M USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | −39.6M USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | −1.69 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS −0.50 USD | |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS −0.30 USD | |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS −0.46 USD | |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS −1.64 USD |
What do people ask about OrthoPediatrics (KIDS)?
What is OrthoPediatrics’ market cap?501.3M
OrthoPediatrics is worth 501.3M USD by market value as of 17 Jul 2026, which is the share price times the shares on issue from its SEC filings.
What is OrthoPediatrics’ revenue?236.3M
OrthoPediatrics reported revenue of 236.3M USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have OrthoPediatrics insiders bought or sold shares recently?21 sales
In the 90 days to 10 Nov 2026, OrthoPediatrics insiders reported 21 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 10 Nov 2025, show no open-market purchase. See Insiders
Which funds own OrthoPediatrics?7 of 45
7 of the 45 funds we track reported a OrthoPediatrics position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Millennium Management, Citadel Advisors and Tudor Investment Corp. See Funds
When did OrthoPediatrics last report earnings?−0.25
OrthoPediatrics last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of −0.25 USD; no next date is announced in SEC filings yet. See Filings

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close)
- TradingViewthe price chart widget, drawn by TradingView from their own data
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings